Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

# Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model

## Abstract

Slow gamma oscillations (30–60 Hz) correlate with retrieval of spatial memory. Altered slow gamma oscillations have been observed in Alzheimer’s disease. Here, we use the J20-APP AD mouse model that displays spatial memory loss as well as reduced slow gamma amplitude and phase-amplitude coupling to theta oscillations phase. To restore gamma oscillations in the hippocampus, we used optogenetics to activate medial septal parvalbumin neurons at different frequencies. We show that optogenetic stimulation of parvalbumin neurons at 40 Hz (but not 80 Hz) restores hippocampal slow gamma oscillations amplitude, and phase-amplitude coupling of the J20 AD mouse model. Restoration of slow gamma oscillations during retrieval rescued spatial memory in mice despite significant plaque deposition. These results support the role of slow gamma oscillations in memory and suggest that optogenetic stimulation of medial septal parvalbumin neurons at 40 Hz could provide a novel strategy for treating memory deficits in AD.

## Introduction

In the hippocampus, rhythmic activity occurs within distinct frequency bands that include theta (θ, 4–12 Hz) and gamma (γ, 30–120 Hz) frequency oscillations. Recently, slow (30–60 Hz) and fast (60–120 Hz) gamma oscillations have been proposed to have functionally distinct roles in memory function1 (see Colgin for review2,3,4). Slow gamma oscillations recorded in CA1 originate from the stratum radiatum (rad) and are coupled to slow gamma oscillations in CA35, a hippocampal subfield essential for memory retrieval6,7. On the other hand, fast gamma oscillations have been suggested to originate from the stratum lacunosum-moleculare (lm) and are coupled to fast gamma oscillations in the medial entorhinal cortex5,8. Slow gamma oscillations have been proposed to support memory retrieval as neuronal activity in the hippocampus can predict exploration of familiar spatial trajectories during epochs of slow gamma oscillations1,9. In spite of evidence suggesting the role of fast and slow gamma oscillations in memory encoding and retrieval, respectively, causal evidence is lacking, in part because of the technical challenges associated with specifically controlling gamma oscillations. In this context, recent advances in the development of optogenetics have allowed the control of neuronal activity at high frequencies and it has been shown that parvalbumin (PV) neurons from the basal forebrain can pace cortical gamma oscillations at ~ 40 Hz when stimulated at that frequency10. Previous neuroanatomical work has shown that PV cells located in the medial septum (MSPV cells) send direct projections to GABAergic interneurons in the hippocampus, giving rise to septohippocampal feedforward inhibitory control11. Among the GABAergic cells receiving inputs from MSPV cells, hippocampal PV interneurons are instrumental in pacing hippocampal oscillations, at least in the theta frequency band12. Supporting this, optogenetic stimulation of MSPV cell projections in the hippocampus are associated with direct, frequency specific pacing of hippocampal oscillations13,14. Although PV interneurons in the hippocampus were shown to be part of a microcircuit regulating memory consolidation15,16, the exact role of MSPV cells in memory encoding and retrieval remains poorly described. Previous reports show that spatial coding remains intact in pyramidal cells during theta oscillation entrainment in spite of a reduction in place cell firing frequency14, but the exact effects of such stimulation in memory tasks has not been addressed yet.

Oscillatory activity in the gamma range is altered in Alzheimer’s disease (AD) patients17,18 and in AD mouse models19,20,21 (see Mably for review22). The mechanisms behind such alterations are not known, but recent evidence suggests that either soluble amyloid beta (Aβ) or its fibrillary forms may affect synaptic and neuronal functions23,24, and would probably contribute to numerous network alterations in rodents25 long before plaques can be detected. In fact, defects of synaptic function and cognition have frequently been reported before any neurodegeneration or plaque deposition can be observed in the brain of transgenic mice overexpressing the amyloid precursor protein (APP)26,27,28, in triple transgenic mice (3xTg)29, as well as in wild-type mice injected with Aβ30,31. Although the coupling of gamma oscillations to theta phase has frequently been reported to support memory processing32,33,34,35 and relies on fast-spiking hippocampal PV interneurons36,37, decreased theta–gamma phase-amplitude coupling has been reported in vitro for an APP mouse model19 as well as in vivo in 3xTg AD mice20, suggesting that altered phase-amplitude coupling could play a key role in AD pathophysiology. Chronic optogenetic stimulation of cortical parvalbumin neurons in AD mouse models was recently shown to reduce levels of Aβ38 and was associated with improved recognition memory39. On the other hand, others have restored both gamma oscillations and normal cognition when upregulating interneuron activity in J20-APP mice40. Although this suggests that slow gamma oscillations may support memory retrieval, and that decrease in gamma oscillations as well as their coupling to theta could be at the origin of memory impairments in AD, the exact contribution of slow gamma oscillation to memory retrieval remains poorly understood. In the current study, we show that APP overexpression leads to spatial memory deficits and that specifically increasing slow gamma oscillations during memory retrieval using optogenetic stimulation is sufficient to ameliorate memory performance in an AD mouse model.

## Results

### Hippocampal gamma oscillations are altered in PVJ20+ mice

In order to examine changes of theta and gamma rhythms in a mouse model that recapitulates some of the hallmarks of AD and allow for optogenetic control of hippocampal oscillations, we generated a mouse line that was obtained by crossing J20 mice overexpressing APP with PV-Cre mice. We termed this new mouse line PVJ20 (Fig. 1a), and compared offsprings that expressed PV-Cre combined with APP overexpression (PVJ20+) to littermates expressing PV-Cre without APP overexpression (PVJ20−). PVJ20+ mice overexpressed APP leading to plaques in the hippocampal formation (supplementary fig. 1a–g) and surrounding cortices at 6 months of age (supplementary fig. 1h–k, supplementary table 1). PVJ20− mice displayed robust spatial memory deficits as measured in the appetitive version of the Barnes maze task (supplementary fig. 2a–d), and failed to alternate successfully in the delayed non-match-to-place task (supplementary fig. 2e–f). Considering that theta and gamma oscillations are highly state dependent and that both increase in power and frequency during running41, we first examined dynamic locomotor-related electrophysiological changes of CA1 hippocampal theta and gamma oscillations during wakefulness, whereas mice freely explored a circular platform (Fig. 1b). In a subset of mice, we implanted silicon probes in PVJ20− and PVJ20+ mice (supplementary fig. 3a) and confirmed their location with histology (supplementary fig. 3b), in addition to ripple power being maximal in the stratum pyramidale (supplementary fig. 3c), and theta phase reversal between the stratum rad and stratum lm (supplementary fig. 3d, e). We measured power spectral densities (PSD) and found reduced slow (30–60 Hz) gamma in PVJ20+ mice (2ANOVA, F(1, 56) = 9.89, p = 0.0027 for the main effect of genotype; n = 6), whereas fast (60–120 Hz) gamma was not significantly different (2ANOVA, F(1,56) = 0.8096, p = 0.3721 for the main effect of genotype; n = 6; supplementary fig. 3f). Comodulograms that represent the coupling strength of gamma (30–120 Hz) amplitudes to theta (4–12 Hz) phases also reveal decreased slow gamma (but not fast gamma) amplitude coupling to theta in the stratum lm in two example mice (supplementary fig. 3h; only theta frequencies with maximum coupling of gamma are preserved in this representation. See supplementary fig. 3g for detailed comodulograms). Consequently, we next focused our analyses in larger groups of mice in the stratum lm using single microelectrodes (Fig. 1c). It is noteworthy that while slow gamma oscillations have been suggested to originate from stratum rad using ICA decomposition5, they can be recorded in stratum lm where theta oscillation amplitudes are the strongest. We took advantage of this feature when normalizing gamma oscillations to theta power, which gave more consistent results. As expected, wavelet spectrograms that resolve both time and frequency of oscillatory signals revealed sustained theta (4–12 Hz) oscillations during active exploration but intermittent gamma oscillations in PVJ20− mice (Fig. 1d, left panel). In PVJ20+ mice, gamma oscillations were decreased in power compared with control PVJ20− littermates (Fig. 1d, right panel), whereas theta oscillations in PVJ20+ mice remained unchanged compared to control PVJ20− littermates (Fig. 1e) both in terms of power (unpaired t test, t18 = 1.437, p = 0.1678; Fig. 1f) as well as frequency (unpaired t test, t18 = 1.278, p = 0.2175; n = 10 PVJ20− mice and n = 10 PVJ20+ mice; Fig. 1g). Because gamma oscillations are transient, whereas theta oscillations are more consistent and comparable between PVJ20− and PVJ20+ mice, we next sorted wavelet convoluted CA1 local field potential (LFP) power in the gamma band and normalized this data to theta power (Fig. 1i). This method allowed us to compare similar behavioral states in both groups. We found that PVJ20+ mice displayed decreased slow gamma (2ANOVA, F(1, 720) = 44.12, P < 0.0001 for main effect of genotype; Fig. 1j) as well as fast gamma (2ANOVA, F(1, 720) = 13.07, p = 0.0003; n = 10 PVJ20− mice and n = 10 PVJ20+ mice; Fig. 1k) power compared with PVJ20− mice. Since gamma oscillations are modulated by the phase of theta oscillations, we also sorted gamma power by theta phase (only considering theta states, where normalized theta exceeded 2 sd) and found that PVJ20+ mice displayed decreased phase-amplitude coupling of slow gamma oscillations compared with PVJ20− littermates (2ANOVA, F(39, 720) = 2.488, p < 0.0001 for interaction between theta phase and slow gamma power, Sidak’s post hoc test; n = 10 PVJ20− mice and n = 10 PVJ20+ mice; Fig. 1l). Interestingly, we found that fast gamma coupling to theta was not altered in PVJ20+ mice (2ANOVA, F(39, 720) = 0.6321, p = 0.9618 for interaction between theta phase and genotype; n = 10 PVJ20− mice and n = 10 PVJ20+ mice; Fig. 1m).

### Optogenetic control of MSPV cells in PVJ20+ mice

Optogenetic stimulation of MSPV neurons14 or their projections to the hippocampus13 are associated with frequency specific pacing of hippocampal oscillations. Owing to the widespread innervation of MSPV neurons in the hippocampus (see supplementary fig. 4c), targeting these neurons directly in the medial septum could provide a powerful and extensive control of hippocampal oscillations. To determine whether hippocampal oscillations could be experimentally generated in PVJ20+ mice, we expressed the ultrafast optogenetic actuator ChETA in MSPV cells of PVJ20+ mice (supplementary fig. 4a, b) as this construct allows better control of neuronal spiking at high stimulation frequencies42. On average, 96.84 ± 1.39% (mean ± SEM) of eYFP cells were parvalbumin-positive (PV+), whereas 86.23 ± 2.45% of PV + cells co-expressed eYFP (n = 15 mice). Expression of eYFP was not found in cholinergic cells (supplementary fig. 4d, e, g). We then determined the accuracy of optogenetic control of MSPV neurons in medial septum slices in vitro (Fig. 2a). MSPV cells were identified by their eYFP expression (Fig. 2b) and their relative lack of frequency adaptation (Fig. 2c). As described previously43,44, these parvalbumin neurons could fire at high frequencies in response to increased injected current (Fig. 2d; supplementary fig. 5b). We then determined optimal illumination duration and intensity for 40 and 80 Hz (which are respectively within slow and fast gamma frequency bands), and thus analyzed responses of MSPV neurons to 40 Hz, 12 ms pulses, and 80 Hz, 6 ms pulses at various laser intensities (Fig. 2e–h; supplementary fig. 5). MSPV cells could be entrained at 40 Hz (Fig. 2e) and 80 Hz (Fig. 2f). We found that both 6 and 12 ms light pulses induced large photocurrents in MSPV cells (RM-2ANOVA, F(1, 4) = 17.13, p = 0.0144), whereas photocurrents were not significantly different between the two pulse widths (RM-2ANOVA, F(1, 4) = 3.905, p = 0.1193; Fig. 2g). In addition, stimulation at both 40 and 80 Hz induced robust responses in MSPV cells (2ANOVA, F(1, 8) = 12.05, p = 0.0084 for the main effect of stimulation wavelength) and did not differ significantly in terms of ability to elicit spikes at 10 mW (2ANOVA, F(1, 8) = 1.109, p = 0.3231; Fig. 2h). We then analyzed hippocampal CA1-LFP responses to MSPV optogenetic stimulation in vivo using the parameters found in MSPV neurons in vitro (Fig. 2i). We determined that optimal responses could be obtained with laser power between 10 and 20 mW (supplementary fig. 6). To generate gamma oscillations in PVJ20+ mice, we compared the effects of 10 Hz (theta band), 40 Hz (slow gamma band), and 80 Hz (fast gamma band) optogenetic stimulation and found that 40 Hz stimulation were most effective at increasing slow gamma power in the hippocampus (1ANOVA, F(3, 30) = 6.202, p = 0.0021; Fig. 2l). Importantly, the power of theta oscillations was not altered by either 40 or 80 Hz optogenetic stimulation (Fig. 2k). Fast gamma band oscillations could not be significantly increased by 80 Hz stimulation (Fig. 3m), which could be owing to the fact that this frequency band is much wider than slow gamma or theta, and that higher frequencies are generally much lower in amplitude than lower frequencies. Nevertheless, this stimulation did induce a significant increase of 80 Hz oscillations as measured by the PSD at that frequency (3.63 ± 0.99 fold baseline PSD, one sample t test, t(6) = 2.633, p = 0.0389; Fig. 2n). We also tested theta-burst stimulation, but this paradigm did not significantly increase slow or fast gamma power (supplementary fig. 7). In one example mouse, we also tested various stimulation frequencies and found frequency specific responses ranging from 5 to 80 Hz (supplementary fig. 8).

### MSPV optogenetic stimulation rescues gamma oscillations

To further assess the effects of the optogenetic stimulation, we used both intra- (638 nm laser stimulation; see supplementary figs. 5 and 6) as well as inter-individual (YFP) controls (Fig. 3b) and performed alternating 2 s periods of 40 Hz stimulation and 2 s without stimulation. This paradigm increased the number of stimulation trials and allowed to sample responses across more behavioral states. We measured the power of slow gamma oscillations over theta phases (Fig. 3c, top row), corresponding stim/baseline ratio (Fig. 3c, bottom row), as well as group averages (Fig. 3d–g). We found that these 40 Hz stimulation increased slow gamma phase-amplitude coupling (2ANOVA, F(1, 6) = 17.93, p = 0.0055 for the main effect of injected construct; Fig. 3d). As expected, 80 Hz optogenetic stimulation did not increase slow gamma phase-amplitude coupling (Fig. 3f). Interestingly, fast gamma phase-amplitude coupling was not increased by 80 Hz stimulation (2ANOVA, F(1, 240) = 1.617, p = 0.2048; Fig. 3g) which could be owing to the fact that PVJ20+ mice do not display altered fast gamma phase-amplitude coupling to theta (Fig. 1m). In contrast, 40 Hz stimulation increased both slow gamma power (2ANOVA, F(1, 12) = 18.63, p = 0.0010; Fig. 3h) as well as theta–gamma coupling strength measured using the modulation index45 (MI; 2ANOVA, F(1, 12) = 12.20, p = 0.0044; Fig. 3f), suggesting that this stimulation pattern could be employed to efficiently restore hippocampal slow gamma oscillations in PVJ20+ mice. Importantly, these effects were not dependent on the phase detection method as both Hilbert transform and a broad-band, peak-to-peak detection method46 provided comparable phase-amplitude coupling responses (supplementary fig. 9). It is noteworthy that during stimulation, there was a significant increase in slow gamma power in PVJ20+ mice (RM-2ANOVA, F(1, 120) = 317.0, p < 0.0001), and when compared with PVJ20− littermates, they did not differ significantly in terms of slow gamma phase-amplitude coupling to theta (2ANOVA, F(1, 480) = 1.231, p = 0.2678), suggesting that 40 Hz stimulation can restore gamma activity to normal levels. In one example mouse, we performed optogenetic stimulation while recording CSD signals from a silicon probe spanning CA1 transversal axis (supplementary fig. 10a, b). Both baseline CSD amplitudes and optogenetic responses were highest in the lm regardless of the stimulation pattern used, whereas only 40 Hz stimulation also elicited significant response in the stratum pyramidale (supplementary fig. 10h).

## Discussion

We found that PVJ20+ mice display decreased gamma oscillations and that specifically reinstating slow gamma oscillations during memory retrieval using optogenetics was sufficient to reverse memory loss. Although previous work has described the effects of chronic optogenetic stimulation39, we show here that memory improvements can be obtained using acute optogenetic treatment. Importantly, we have separated analyses of gamma power and phase-amplitude coupling and have found that both slow and fast gamma power were reduced at comparable theta amplitudes, results that are comparable with those previously found in both J20-APP40 and taupathy51 mouse models. We also observed that only the coupling of slow gamma amplitude to theta phases was reduced, with fast gamma coupling remaining intact, which was also found in a 3xTg mouse model20. We have summarized in supplementary table 2 our behavioral data including the effects of optogenetic treatment on hippocampal physiology.

Although some studies have focused on decreasing plaque load to improve brain function in APP mice38,39,52,53, there is a large body of evidence showing that Aβ deposits do not correlate significantly with AD progression in humans54,55,56,57,58,59,60,61. In that respect, our results support recent findings that memory can be improved in the absence of Aβ clearance by applying optogenetic stimulation specifically during memory retrieval50,62. In contrast to previous studies suggesting that AD alters encoding functions47,48,49, or reconsolidation63, our results are in agreement with AD memory dysfunction being related to defects in memory retrieval50,62. Stimulation during retrieval was sufficient to restore memory performance, which suggests that encoding processes are maintained in PVJ20 mice. Although stimulating during encoding did not significantly increase memory performance, we did observe higher scores in some of the mice tested. Further in-depth behavioral investigation of acute optogenetic stimulation could shed light on such memory improvements.

Considering that MSPV neurons project directly onto GABAergic interneurons in the hippocampus11, it is likely that our optogenetic stimulation modulates the excitability of hippocampal pyramidal neurons to some extent. Although release of feedforward inhibition would be expected, previous studies have described reduction of place cell peak firing frequency during such stimulation, at least when stimulating MSPV interneurons in the theta band14. Interestingly, we found that in vitro, MSPV cells display a wide range of maximum firing frequencies, as shown previously43,44. This could explain in part the discrepancies in our ability to control their activity for high frequencies at the single cell level in vitro, whereas we were successful in pacing hippocampal rhythms up to 80 Hz in vivo. Importantly, our optogenetic gamma stimulation did not alter theta power, frequency, or phase distribution and did not alter locomotion or anxiety behavior in behaving mice. Based on our histological and in vivo results, we hypothesize that our optogenetic stimulation can realistically only control a portion of the MSPV cell population. Moreover, despite the absence of ChETA transfection in cholinergic cells in our conditions, indirect cholinergic effects cannot be entirely excluded since ~ 10% of GABAergic project onto cholinergic cells within the medial septum64. Although we found that MSPV interneurons are silent in vitro, these cells were previously found to be frequency-locked to theta oscillations during theta states65, and locked to varying theta phases66. Considering our findings in vivo, it is likely that these cells preserve their phase locking to theta while being entrained at higher (40, 80 Hz) frequencies. Further studies employing dedicated single unit recordings of MSPV cells during optogenetic stimulation should be performed to confirm that this is indeed the case. Furthermore, although using single electrodes has allowed us to increase the statistical power of our results, these recording conditions do not permit independent component analysis (ICA) or other decomposition methods that would allow us to identify gamma generators within the hippocampus, and the associated effects of optogenetic stimulation on them. Therefore, while our optogenetic stimulation could generate artificial slow and fast gamma rhythms in hippocampal layers that normally do not exhibit such oscillations, our stimulation might either be associated with increased natural gamma oscillations, or a superimposition of natural and artificial gamma oscillations.

Treatments for AD that target Aβ have not been successful so far. In part, this is probably owing to the fact that synaptic alterations occur long before plaques can be detected67,68. Our study is relevant in the context of AD treatment as we found that acute optogenetic stimulation is sufficient to control gamma oscillations directly and reinstate memory recall. Our results suggest that more direct neural network manipulations could be employed as novel therapeutics to reverse memory loss in AD, and supports the role of hippocampal slow gamma oscillations in spatial memory retrieval.

## Methods

### Animals

All procedures were approved by the McGill University Animal Care Committee and the Canadian Council on Animal Care. Male mice expressing a mutant form of the human amyloid protein precursor bearing both the Swedish (K670N/M671L) and the Indiana (V717F) mutations (APPSwInd) under the control of the PDGFB promoter [B6. Cg-Tg(PDGFB-APPSwInd)28, (Jackson laboratory)] were bred with female parvalbumin-cre mice (Jackson Laboratory). This mouse line is termed PVJ20 throughout the current study. A total of n = 87 PVJ20 mice were used in this study (n = 44 PVJ20 + , n= 43 PVJ20−). n = 31 mice were implanted with fiber optic implants to perform combined optogenetics and freely moving behavior, n = 6 mice were implanted with linear silicon probes, n = 40 mice were implanted with electrode arrays, and n = 10 mice were used for patch-clamp electrophysiology.

Adeno-associated viruses (AAV) of serotype dj (hybrid capsid created from eight different AAV serotypes) were obtained from the Vector Core Facility at Oregon Health and Science University in Portland, Oregon. The AAVdj virus contained a channelrhodopsin-2 with the E123T mutation for ultrafast control (ChETA construct) fused to eYFP in a double-floxed, inverted, open-reading-frame (DIO) driven by the EF1α promoter (5.2 E + 13 vg/ml genomic titer). An eYFP construct without the ChETA sequence was used as a control (termed YFP control in this manuscript).

### Surgical procedures

Mice were anesthetized with isoflurane (5% induction, 0.5–2% maintenance) and placed in a stereotaxic frame (Stoelting). The skull was completely cleared of all connective tissue. AAVdj-ChETA or eYFP was delivered into the medial septum (0.6 μl at 1 nL/s), at the following coordinates based on reference mouse stereotaxic atlas69: anteroposterior (AP) 0.85 mm from bregma, mediolateral (ML) 0 mm, dorsoventral (DV) − 4.50 mm using a 5° angle in the ML plane. Two weeks post-injection, mice were anesthetized for implantation surgery. In all, 200 μm diameter fiber optic with ceramic ferrule (Thor labs) implants were implanted at the same coordinates as for injections and cemented in place using C&B-Metabond (Patterson dental, MN). For mice used for electrophysiology experiments, an array of seven tungsten microelectrodes (~ 1 MΩ impedance) was lowered in dorsal CA1 spanning through stratum pyramidale (pyr), stratum radiatum (rad), and stratum lacunosum moleculare (lm). Screws placed in the bone above the frontal cortex and cerebellum served as ground and reference, respectively. Following electrode, ground and reference placement, dental cement was applied to secure the implant permanently to the skull. Black nail polish was applied over the dental cement to block light emission during optogenetic stimulation.

### In vivo electrophysiological recordings

Following 1 week of post-surgical recovery and one week of habituation to the tethering setup, LFP from implanted mice was recorded. All recorded signals from implanted electrodes were amplified by the tether pre-amplifier before being digitized at 22 KHz using a digital recording system (Neuralynx, USA).

### Optogenetic stimulation

Laser stimulation was delivered through a fiber optic cord (200 μm diameter) using a laser diode fiber light source (Doric Lenses, Canada). Light intensity was calibrated and wavelength-corrected using the Power Meter Bundle with the PM100D Console and S130C Slim Photodiode Sensorlight (Thorlabs) both in vitro and in vivo. Unless stated differently, every stimulation was performed at 50% duty cycle, which allowed the use of identical total illumination duration at all stimulation frequencies. To compute input–output (IO) curves, mice were allowed to freely explored a novel open-field and received stimulation with a 5 s ON, 5 s OFF schedule. When applying optogenetic stimulation during behavior, a loose piece of heat shrink tubing was fitted around the junction between the patch cord and the mouse’ ferrule implant to limit visible light emission. Light intensities are expressed as nominal power, as measured at the tip of the fiber optic implant—cord assembly, and corrected for each wavelength.

### Novel object place recognition

On the first day, mice were allowed to freely explore a 45 × 45 cm dark gray open-field that contained visual cues (large white horizontal and vertical gratings) on its walls for 10 min. On the second day, two identical objects (helping hand base) were presented for 10 min. On the third day, mice were allowed to explore the same open field and the location of one of the two objects was displaced. To control for potential spatial preference biases, both the initial as well as the displaced position of objects was randomized. Mice were attributed a random testing order that was kept identical throughout the three days of testing. Behavior was recorded with a video camera and analyzed offline using Optimouse, an open-source Matlab toolbox that allows for the detection of both mouse body and nose position70. Behavioral analysis was performed blind to the genotype and treatment. Object explorations are defined as epochs where mice have their nose within 1 cm of an object.

To circumvent the inability of tethered mice to perform the standard Barnes maze task (escape through a hole) we used an appetitive version. Mice were water scheduled (2 h per day) and trained to seek a 50 μL, 10% sucrose water reward in one of the 20 locations (~ 2 cm cups) of a 1 m diameter dark gray circular platform. Mice performed three trials per day for a total of five consecutive days. Spatial errors were defined as the exploration of an unbaited location (the maximum number of spatial errors is 19). On the 6th day, mice were subjected to a probe test (150 s), which consisted of a free exploration in absence of any reward. Mice exploration was recorded and the percent of time in the target quadrant was computed (chance level at 25%).

### Delayed non-match to place task

Mice were water scheduled (2 h per day) and trained in a Y-maze to a delayed non-match to place task. In brief, each trial was divided into two phases: sample and test. In the sample phase, one arm was blocked and mice were forced to explore the opposite arm where they received a 10% sucrose water reward. In all, 30 s after completing the sample phase, mice were placed back in the central arm for the test phase, during which both arms could be explored. In the test phase, only the opposite (unexplored) arm is baited, so that mice have to alternate locations between sample and test phases. Mice were subjected to 10 trials (sample + test) per day, for 10 consecutive days, and the daily success rate was calculated at the number of correct choices divided by the total number of trials.

### Histology

After completion of behavioral testing, mice were deeply anesthetized with a mixture ketamine/xylazine/acepromazide (100, 16, 3 mg/kg, respectively, intraperitoneal injection). For mice implanted with electrodes, microlesions were performed by passing a current of ~ 10 µA for 10–20 s through each electrode using a Nano Z (Neuralynx, USA) to identify electrode tips. Mice were then perfused transcardially with 4% paraformaldehyde in PBS (PFA). The brains were extracted and postfixed overnight in PFA at 4°C and subsequently washed in PBS for an additional 24 h at 4°C. Brains and sections were cryoprotected in solution of 30% ethylene glycol, 30% glycerol, and 40% PBS until used. Each brain was then sectioned at 50 µm using a vibratome: every section was sequentially collected in four different 1.5 mL tubes to allow different analyses (electrode location, plaque analyses, immunohistochemistry).

### Immunohistology

Using one tube of collected brain sections (25% sampling), sections were washed 3 × 5 min in PBS to remove cryoprotective solution. Sections were first incubated overnight with PGT (0.45% Gelatin and 0.25% Triton in PBS) at 4°C. Next, slices were incubated with primary antibodies (1:1000 rabbit anti-GFP from Life Technologies, and 1:500 mouse anti-parvalbumin monoclonal IgG1 from Sigma-Aldrich) in PGT at room temperature for 2 h. Following washes of 10, 20, and 30 min, sections were then incubated with secondary antibodies [1:1000 goat anti-rabbit coupled with Alexa 488 (Molecular Probes), and 1:500 goat anti-mouse IgG1 coupled to Alexa 555 (Life Technologies)] in PGT for 45 min. Following 10, 20, and 30 min washes, sections were then mounted on glass slides and permanently coverslipped with Fluoromount mounting medium that contained 4′,6-diamidino-2-phenylindole. Only mice with histologically confirmed placement of at least one electrode in CA1 stratum lacunosum moleculare and optic fiber placement as well as proper construct expression in the medial septum were used in the present study. To control for co-expression with cholinergic neurons, we performed double fluorescent immunohistochemistry for eYFP and Choline acetltransferase (ChAT). In that case, sections were incubated for 12 h with primary antibodies (1:200 goat anti-ChAT from Millipore and 1:1000 chicken anti-GFP from ThermoFisher Scientific) in PGT at 4°C. Sections were then washed in PGT and incubated with secondary antibodies (1:2000 donkey anti-goat coupled with Alexa 647, and 1:2000 donkey anti-chicken coupled with Alexa 488 from Jackson Immunoresearch) for 45 min at room temperature. Sections were washed and mounted as described above.

### Thioflavine S staining

To confirm the presence of oligomeric and non-oligomeric plaques in our newly generated PVJ20 mouse line, performed thioflavine S staining on brain tissue. In brief, coronal, 50 μm sections were mounted on glass slides and left to dry for ~ 1–2 h. Slides were then immersed in PBS containing 1% thioflavine S for 8 min. After clearing with absolute ethanol and PBS, slides were coverslipped and Thioflavine S positive plaques were imaged with a fluorescence microscope using a GFP dichroic cube.

### In vitro patch-clamp electrophysiology

Mice were deeply anesthetized using ketamine/xylazine/acepromazine mix, and intracardially perfused with N-methyl-d-glutamine (NMDG) recovery solution (4°C) oxygenated with carbogen (5% CO2 and 95% O2). NMDG solution contains the following (in mm): 93 NMDG, 93 HCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, five sodium ascorbate, two thiourea, three sodium pyruvate, adjusted pH 7.4 with HCl before adding 10 MgSO4 and 0.5 CaCl2. Following NMDG perfusion, brains were quickly removed and immersed for an extra 1 min in cold NMDG recovery solution. Coronal slices (300 µm) were cut using a vibrating microtome (Leica-VT1000S), then collected in 32°C NMDG recovery solution for 10–12 min. Slices were transferred to room temperature and oxygenated artificial cerebrospinal fluid (aCSF) containing the following (in mm): 124 NaCl, 24 NaHCO3, 2.5 KCl, 1.2 NaH2PO4, 2 MgSO4, 5 HEPES, 2 CaCl2, and 12.5 glucose (pH 7.4). Patch pipettes (3–5 MΩ) were filled with internal solution, containing the following (in mm): 140 K gluconate, 2 MgCl2, 10 Hepes, 0.2 EGTA, 2 NaCl, 2 mm Na2-ATP and 0.3 mm Na2-GTP, adjusted pH to 7.7 with KOH, adjusted osmolarity to 290. Slices were transferred to a submerged recording chamber filled with aCSF (4 ml /min flow rate, 30 °C), continuously oxygenated with carbogen (5% CO2 and 95% O2). Single whole cell patch-clamp recordings of parvalbumin neurons (identified by YFP fluorescence) were done after transferring brain slices to the recording chamber. All recordings were done at 32 °C. For recordings, parvalbumin interneurons were either tested in current clamp mode (resting potential between −60 and −70 mV) or maintained at −70 mV in voltage-clamp mode. For both, the effect of different intensities of red light (638 nm) and blue light (450 nm) was tested (1–20 mW), using a laser diode fiber light source (Doric Lenses, QC, Canada). No spikes could be elicited using 450 nm stimulation in eYFP (control) transfected cells, as well as using 638 nm stimulation in eYFP-transfected cells. Electrophysiological signals were amplified, using a Multiclamp 700B patch-clamp amplifier (Axon Instruments, CA, USA), sampled at 20 kHz, filtered at 10 kHz. Data were analyzed using pClamp 10 (Molecular devices, CA, USA).

### Analysis

Data analysis was performed using custom written Matlab codes available upon request. For silicon probe data, current source density (CSD) was calculated from 16-channel silicon probe LFP recordings using Equation (1)

$${\mathrm{CSD}}_{\left( {x,t} \right)} = \frac{{\sigma \left( {2x_t - \left( {x + {\mathrm{\Delta }}x_t} \right) - \left( {x - {\mathrm{\Delta }}x_t} \right)} \right)}}{{\left( {{\mathrm{\Delta }}x} \right)^2}}$$
(1)

where xt is the potential at depth x for time point t, with Δx = 50 μm. Conductivity (σ) was assumed constant. Wavelet convolution was applied to LFP signals using complex Morlet wavelets (‘cmor1-1.5’ in Matlab) when both time- and frequency-domain accuracy was needed, and in particular when natural gamma oscillations had to be visualized and for theta power-sorted spectrograms in Figs. 1 and 4. Moving window Fourier convolution (2 s window in the theta band, 5 s window in the gamma band, 10 ms moving steps) was used when frequency-domain accuracy was privileged over time-domain accuracy.

### Phase-amplitude coupling

For analyses of coupled oscillations, theta phase was obtained by bandpass filtering signals between 4 and 12 Hz and performing a Hilbert transform. Although the Hilbert transform is most commonly used to obtain phase of oscillations, it was found to dampen the asymmetry that is naturally observed in theta rhythms46. To control for this effect, we also computed theta phase using the method described in Belluscio et al.46. In brief, raw traces were filtered between 1 and 60 Hz and peaks, trough, as well as zero crossing points were determined from these traces and linearly interpolated to provide phase information. In 2 s, non-overlapping sliding windows, theta phase obtained from either method was then binned in 40 bins of 9° and slow as well as fast gamma power was then averaged for each theta phase bin. Typically, most studies perform z-scoring of filtered gamma oscillation derived power to analyze coupling. We found that doing so often scales up/down phase-amplitude coupling values and mask differences in gamma power between groups. Therefore, in the current study, z-scoring is performed on the raw, unfiltered trace only in the context of phase-amplitude coupling. This method allows to reveal both increase in coupling and baseline gamma power described in Fig. 3. We also used more traditional measures such as the modulation index (MI) that was computed as the Kullback–Leibler distance between binned gamma amplitudes across theta phases and a linear distribution of gamma amplitudes45. To assess effects of laser stimulation in the theta band, we used entrainment fidelity13 as a measure of how much the stimulated frequency (± 0.5 Hz) is represented among the theta band. For instance, entrainment fidelity of 60% for a 10 Hz stimulation means that 60% of theta band is found between 9.5 and 10.5 Hz.

### Statistics

All data are presented as mean ± standard error of the mean (SEM) and statistic test details are described in the corresponding results. All t tests were two-tailed. Normality distribution of each group was assessed using Shapiro–Wilk normality test and parametric tests were used only when distributions were found normal (non-parametric tests are described where applicable). Effect size of repeated measure ANOVA was assessed with partial η2 using Equation (2)

$${\mathrm{partial}}\,{\upeta}^2 = \frac{{{\mathrm{SS}}_{{\mathrm{effect}}}}}{{{\mathrm{SS}}_{{\mathrm{effect}}} + {\mathrm{SS}}_{{\mathrm{error}}}}}$$
(2)

1ANOVA: one-way ANOVA; 2ANOVA: two-way ANOVA; RM-1ANOVA: repeated measure one-way ANOVA. RM-2ANOVA: repeated measure two-way ANOVA. p < 0.05 was considered statistically significant. *, p < 0.05; **, p < 0.01; ***, p < 0.001, ****, p < 0.0001.

### Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

## Code availability

All the codes used in the current study are available from the corresponding author upon request.

## Data availability

The data supporting the findings of this study is available with the article and its Supplementary Information file, or is available from the corresponding author upon request. The source data underlying Figs. 1f–h, j–m, 2d–h, k–n, 3c–j, 4c–f, j–l, n, and Supplementary Figs 1c–e, 2b, d, f, 3f, 4e–g, 5b, c, e, g, 6d–h, 7d–f, 9b–d, 10f, h, j, 11b, c are provided as a Source Data file.

## References

1. 1.

Zheng, C., Bieri, K. W., Hsiao, Y. T. & Colgin, L. L. Spatial sequence coding differs during slow and fast gamma rhythms in the hippocampus. Neuron 89, 398–408 (2016).

2. 2.

Colgin, L. L. Do slow and fast gamma rhythms correspond to distinct functional states in the hippocampal network? Brain Res. 1621, 309–315 (2015).

3. 3.

Colgin, L. L. Theta-gamma coupling in the entorhinal-hippocampal system. Curr. Opin. Neurobiol. 31, 45–50 (2015).

4. 4.

Colgin, L. L. Rhythms of the hippocampal network. Nat. Rev. Neurosci. 17, 239–249 (2016).

5. 5.

Schomburg, E. W. et al. Theta phase segregation of input-specific gamma patterns in entorhinal-hippocampal networks. Neuron 84, 470–485 (2014).

6. 6.

Nakazawa, K. et al. Requirement for hippocampal CA3 NMDA receptors in associative memory recall. Science 297, 211 (2002).

7. 7.

Steffenach, H.-A., Sloviter, R. S., Moser, E. I. & Moser, M.-B. Impaired retention of spatial memory after transection of longitudinally oriented axons of hippocampal CA3 pyramidal cells. Proc. Natl Acad. Sci. 99, 3194–3198 (2002).

8. 8.

Colgin, L. L. et al. Frequency of gamma oscillations routes flow of information in the hippocampus. Nature 462, 353–357 (2009).

9. 9.

Bieri, K. W., Bobbitt, K. N. & Colgin, L. L. Slow and fast gamma rhythms coordinate different spatial coding modes in hippocampal place cells. Neuron 82, 670–681 (2014).

10. 10.

Kim, T. et al. Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations. Proc. Natl Acad. Sci. 112, 3535 (2015).

11. 11.

Unal, G., Joshi, A., Viney, T. J., Kis, V. & Somogyi, P. Synaptic targets of medial septal projections in the hippocampus and extrahippocampal cortices of the mouse. J. Neurosci. 35, 15812–15826 (2015).

12. 12.

Amilhon, B. et al. Parvalbumin interneurons of hippocampus tune population activity at theta frequency. Neuron 86, 1277–1289 (2015).

13. 13.

Bender, F. et al. Theta oscillations regulate the speed of locomotion via a hippocampus to lateral septum pathway. Nat. Commun. 6, 8521 (2015).

14. 14.

Zutshi, I. et al. Hippocampal neural circuits respond to optogenetic pacing of theta frequencies by generating accelerated oscillation frequencies. Curr. Biol. 28, 1179–1188.e3 (2018).

15. 15.

Xia, F. et al. Parvalbumin-positive interneurons mediate neocortical-hippocampal interactions that are necessary for memory consolidation. eLife 6, 1–25 (2017).

16. 16.

Donato, F., Rompani, S. B. & Caroni, P. Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning. Nature 504, 272–276 (2013).

17. 17.

Herrmann, C. & Demiralp, T. Human EEG gamma oscillations in neuropsychiatric disorders. Clin. Neurophysiol. 116, 2719–2733 (2005).

18. 18.

van Deursen, J. A., Vuurman, E. F. P. M., Verhey, F. R. J., van Kranen-Mastenbroek, V. H. J. M. & Riedel, W. J. Increased EEG gamma band activity in Alzheimer’s disease and mild cognitive impairment. J. Neural Transm. 115, 1301–1311 (2008).

19. 19.

Goutagny, R. et al. Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer’s disease. Eur. J. Neurosci. 37, 1896–1902 (2013).

20. 20.

Mably, A. J., Gereke, B. J., Jones, D. T. & Colgin, L. L. Impairments in spatial representations and rhythmic coordination of place cells in the 3xTg mouse model of Alzheimer’s disease. Hippocampus 27, 378–392 (2017).

21. 21.

Mondragón-Rodríguez, S., Gu, N., Manseau, F. & Williams, S. Alzheimer’s transgenic model is characterized by very early brain network alterations and β-CTF fragment accumulation: reversal by β-secretase inhibition. Front. Cell Neurosci. 12, 121 (2018).

22. 22.

Mably, A. J. & Colgin, L. L. Gamma oscillations in cognitive disorders. Curr. Opin. Neurobiol. 52, 182–187 (2018).

23. 23.

Walsh, D. M. & Selkoe, D. J. Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron 44, 181–193 (2004).

24. 24.

Vico Varela, E., Etter, G. & Williams, S. Excitatory-inhibitory imbalance in Alzheimer’s disease and therapeutic significance. Neurobiol. Dis. 127, 605–615 (2019).

25. 25.

Palop, J. J. Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66, 435 (2009).

26. 26.

D’Hooge, R., Nagels, G., Westland, C. E., Mucke, L. & De, P. D. Spatial learning deficit in mice expressing human 751-amino acid beta-amyloid precursor protein. Neuroreport 7, 2807–2811 (1996).

27. 27.

Giacchino, J., Criado, J. R., Games, D. & Henriksen, S. In vivo synaptic transmission in young and aged amyloid precursor protein transgenic mice. Brain Res. 876, 185–190 (2000).

28. 28.

Mucke, L. et al. High-level neuronal expression of Aβ 1-42 in wild-type Human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050–4058 (2000).

29. 29.

Oddo, S. et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409–421 (2003).

30. 30.

Balducci, C. et al. Synthetic amyloid- oligomers impair long-term memory independently of cellular prion protein. Proc. Natl Acad. Sci. 107, 2295–2300 (2010).

31. 31.

Shankar, G. M. et al. Amyloid-β protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat. Med. 14, 837–842 (2008).

32. 32.

Tort, A. B. L. et al. Dynamic cross-frequency couplings of local field potential oscillations in rat striatum and hippocampus during performance of a T-maze task. Proc. Natl Acad. Sci. 105, 20517–20522 (2008).

33. 33.

Tort, A. B. L., Komorowski, R. W., Manns, J. R., Kopell, N. J. & Eichenbaum, H. Theta–gamma coupling increases during the learning of item–context associations. Proc. Natl Acad. Sci. 106, 20942 (2009).

34. 34.

Händel, B. & Haarmeier, T. Cross-frequency coupling of brain oscillations indicates the success in visual motion discrimination. NeuroImage 45, 1040–1046 (2009).

35. 35.

Canolty, R. T. & Knight, R. T. The functional role of cross-frequency coupling. Trends Cogn. Sci. 14, 506–515 (2010).

36. 36.

Bartos, M. et al. Fast synaptic inhibition promotes synchronized gamma oscillations in hippocampal interneuron networks. Proc. Natl Acad. Sci. 99, 13222–13227 (2002).

37. 37.

Wulff, P. et al. Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons. Proc. Natl Acad. Sci. 106, 3561–3566 (2009).

38. 38.

Iaccarino, H. F. et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540, 230–235 (2016).

39. 39.

Martorell, A. J. et al. Multi-sensory gamma stimulation ameliorates Alzheimer’s-associated pathology and improves cognition. Cell 177, 256–271.e22 (2019).

40. 40.

Martinez-Losa, M. et al. Nav1.1-overexpressing interneuron transplants restore brain rhythms and cognition in a mouse model of Alzheimer’s disease. Neuron 98, 75–89.e5 (2018).

41. 41.

Chen, Z., Resnik, E., McFarland, J. M., Sakmann, B. & Mehta, M. R. Speed controls the amplitude and timing of the hippocampal gamma rhythm. PLoS ONE 6, e21408 (2011).

42. 42.

Gunaydin, L. A. et al. Ultrafast optogenetic control. Nat. Neurosci. 13, 387–392 (2010).

43. 43.

Sotty, F. et al. Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity. J. Physiol. 551, 927–943 (2003).

44. 44.

Manseau, F., Goutagny, R., Danik, M. & Williams, S. The hippocamposeptal pathway generates rhythmic firing of GABAergic neurons in the medial septum and diagonal bands: an investigation using a complete septohippocampal preparation in vitro. J. Neurosci. 28, 4096 (2008).

45. 45.

Tort, A. B. L., Komorowski, R., Eichenbaum, H. & Kopell, N. Measuring phase-amplitude coupling between neuronal oscillations of different frequencies. J. Neurophysiol. 104, 1195–1210 (2010).

46. 46.

Belluscio, M. A., Mizuseki, K., Schmidt, R., Kempter, R. & Buzsáki, G. Cross-frequency phase–phase coupling between theta and gamma oscillations in the hippocampus. J. Neurosci. 32, 423 (2012).

47. 47.

Granholm, E. & Butters, N. Associative encoding and retrieval in Alzheimer’s and Huntington’s disease. Brain Cogn. 7, 335–347 (1988).

48. 48.

Hodges, J. R., Salmon, D. P. & Butters, N. Differential impairment of semantic and episodic memory in Alzheimer’s and Huntington’s diseases: a controlled prospective study. J. Neurol. Neurosurg. Psychiatry 53, 1089–1095 (1990).

49. 49.

Weintraub, S., Wicklund, A. H. & Salmon, D. P. The neuropsychological profile of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006171–a006171 (2012).

50. 50.

Roy, D. S. et al. Memory retrieval by activating engram cells in mouse models of early Alzheimer’s disease. Nature 531, 508–512 (2016).

51. 51.

Booth, C. A. et al. Altered intrinsic pyramidal neuron properties and pathway-specific synaptic dysfunction underlie aberrant hippocampal network function in a mouse model of tauopathy. J. Neurosci. 36, 350–363 (2016).

52. 52.

Liao, F. et al. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of a amyloidosis. J. Neurosci. 34, 7281–7292 (2014).

53. 53.

Wyss-Coray, T. et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med 7, 612–618 (2001).

54. 54.

Berg, L., McKeel, D. W., Miller, J. P., Baty, J. & Morris, J. C. Neuropathological indexes of Alzheimer’s disease in demented and nondemented persons aged 80 years and older. Arch. Neurol. 50, 349–358 (1993).

55. 55.

Bierer, L. M. et al. Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer’s disease. Arch. Neurol. 52, 81–88 (1995).

56. 56.

Dickson, D. W. et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13, 179–189 (1992).

57. 57.

Guillozet, A. L., Weintraub, S., Mash, D. C. & Mesulam, M. M. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch. Neurol. 60, 729 (2003).

58. 58.

Schmitt, F. A. et al. ‘Preclinical’ AD revisited: Neuropathology of cognitively normal older adults. Neurology 55, 370–376 (2000).

59. 59.

Lue, L.-F., Brachova, L., Civin, W. H. & Rogers, J. Inflammation, Aβ deposition, and neurofibrillary tangle formation as correlates of Alzheimer’s disease neurodegeneration. J. Neuropathol. Exp. Neurol. 55, 1083–1088 (1996).

60. 60.

SantaCruz, K. S. et al. Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the nun study and the adult changes in thought study. J. Neuropathol. Exp. Neurol. 70, 832–840 (2011).

61. 61.

Vassilaki, M. et al. Association between functional performance and Alzheimer’s disease biomarkers in individuals without dementia. J. Am. Geriatr. Soc. 66, 2274–2281 (2018).

62. 62.

Perusini, J. N. et al. Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer’s disease mice. Hippocampus 27, 1110–1122 (2017).

63. 63.

Ohno, M. Failures to reconsolidate memory in a mouse model of Alzheimer’s disease. Neurobiol. Learn. Mem. 92, 455–459 (2009).

64. 64.

Leão, R. N., Targino, Z. H., Colom, L. V. & Fisahn, A. Interconnection and synchronization of neuronal populations in the mouse medial septum/diagonal band of Broca. J. Neurophysiol. 113, 971–980 (2014).

65. 65.

Hangya, B., Borhegyi, Z., Szilágyi, N., Freund, T. F. & Varga, V. GABAergic neurons of the medial septum lead the hippocampal network during theta activity. J. Neurosci. 29, 8094 (2009).

66. 66.

Borhegyi, Z. Phase Segregation of Medial Septal GABAergic Neurons during Hippocampal Theta Activity. J. Neurosci. 24, 8470–8479 (2004).

67. 67.

Selkoe, D. J. Alzheimer’s disease is a synaptic failure. Science 298, 789–791 (2002).

68. 68.

Selkoe, D. J. Preventing Alzheimer’s disease. Science 337, 1488 (2012).

69. 69.

Paxinos, G. & Watson, C. The rat brain in stereotaxic coordinates. Acad. Press Inc 439 (1997). https://doi.org/10.1016/0166-2236(87)90017-8.

70. 70.

Ben-Shaul, Y. OptiMouse: a comprehensive open source program for reliable detection and analysis of mouse body and nose positions. BMC Biol. 15, 41 (2017).

## Acknowledgements

We thank Mark Brandon and Joseph MacNeil for helpful comments on the manuscript. Ke Cui for help maintaining the colony and perfusing mice. This work is supported by Brain Canada, Fonds de la recherche en Santé du Québec (FRSQ), the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Alzheimer Society of Canada. GE was supported by Brain Canada, the Roger J. Paiement Outreach Award and the Douglas Institute Foundation.

## Author information

Authors

### Contributions

G.E. and S.W. designed the study. G.E. performed and analyzed in vivo optogenetic and behavioral experiments. S.V.D.V. and I.Z. performed immunohistological experiments. I.Z. and S.V.D.V. analyzed immunohistological data. F.M. and E.T.D. performed and analyzed patch-clamp in vitro electrophysiology. G.E. and S.W. wrote the manuscript with inputs from all collaborators.

### Corresponding author

Correspondence to Sylvain Williams.

## Ethics declarations

### Competing interests

The authors declare no competing interests.

Peer review information Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

## Rights and permissions

Reprints and Permissions

Etter, G., van der Veldt, S., Manseau, F. et al. Optogenetic gamma stimulation rescues memory impairments in an Alzheimer’s disease mouse model. Nat Commun 10, 5322 (2019). https://doi.org/10.1038/s41467-019-13260-9

• Accepted:

• Published:

• DOI: https://doi.org/10.1038/s41467-019-13260-9

• ### Differences in verbal and spatial working memory in patients with bipolar II and unipolar depression: an MSI study

• Zhinan Li
• Junhao Chen
• Yanbin Jia

BMC Psychiatry (2021)

• ### Ablation of p75NTR signaling strengthens gamma–theta rhythm interaction and counteracts Aβ-induced degradation of neuronal dynamics in mouse hippocampus in vitro

• Hugo Balleza-Tapia
• André Fisahn

Translational Psychiatry (2021)

• ### Septohippocampal transmission from parvalbumin-positive neurons features rapid recovery from synaptic depression

• Feng Yi
• Tavita Garrett
• J. Josh Lawrence

Scientific Reports (2021)

• ### Toward integrative approaches to study the causal role of neural oscillations via transcranial electrical stimulation

• Valeriia Beliaeva
• Iurii Savvateev
• Rafael Polania

Nature Communications (2021)

• ### Illuminating Neural Circuits in Alzheimer’s Disease

• Yang Ying
• Jian-Zhi Wang

Neuroscience Bulletin (2021)